The World Health Organization will convene an extraordinary meeting next week to discuss the “unusual and disturbing” outbreak of monkeypox

The World Health Organization will convene an extraordinary meeting next week to discuss the "unusual and disturbing" outbreak of monkeypox

The global monkeypox outbreak is “obviously unique and worrying,” according to WHO Director-General Tedros Adhanom Ghebreyesus, who also announced the formation of an emergency committee next week to determine whether the outbreak is a public health emergency of international concern. So far this year, the World Health Organization (WHO) has received reports of almost 1,600 confirmed and nearly 1,500 suspected cases of monkeypox from 39 countries, including seven where monkeypox has been recognised for years and 32 newly-affected nations, according to Ghebreyesus. Furthermore, 72 deaths have been reported from previously afflicted countries so far this year.

The IHR are an instrument of international law that is legally-binding on 196 countries, including the 194 WHO Member States. The WHO published interim guidance on the use of smallpox vaccines for monkeypox. Ghebreyesus said that the global health organisation does not recommend mass vaccination against monkeypox.

No deaths have been reported so far from the newly-affected countries, although the WHO is seeking to verify news reports from Brazil over a monkeypox-related death. “The global outbreak of monkeypox is clearly unusual and concerning. It’s for that reason that I have decided to convene the Emergency Committee under the International Health Regulations next week to assess whether this outbreak represents a public health emergency of international concern,” he said. As per the WHO, while disease outbreaks and other acute public health risks are often unpredictable and require a range of responses, the International Health Regulations (2005) (IHR) provide an overarching legal framework that defines countries’ rights and obligations in handling public health events and emergencies that have the potential to cross borders.

“While smallpox vaccines are expected to provide some protection against monkeypox, there is limited clinical data, and limited supply,” he said, adding that any decision about whether to use vaccines should be made jointly by individuals who may be at risk and their healthcare provider, based on an assessment of risks and benefits, on a case-by-case basis. Ghebreyesus said that the WHO’s goal is to support countries to contain monkeypox transmission and stop the outbreak with tried-and-tested public health tools including surveillance, contact-tracing and isolation of infected patients.

 

He stressed “it is also essential to increase awareness of risks and actions to reduce onward transmission for the most at-risk groups, including men who have sex with men and their close contacts”. “It’s also essential that vaccines are available equitably wherever needed. To that end, WHO is working closely with our Member States and partners to develop a mechanism for fair access to vaccines and treatments,” he said. The WHO is also working with partners and experts from around the world on changing the name of monkeypox virus, its clades and the disease it causes.

Check the latest news about World news section for best information.

The best source of news - newszf.com
Logo
Compare items
  • Total (0)
Compare
0